X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

June 13, 2019

Key Takeaways from FDA Public Meeting on Outsourcing Facilities, cGMP and Office Stock

Members of the West Pharmaceutical Services, Inc. (West) Marketing Unit had the pleasure of attending the recent FDA Public Meeting on Tuesday, May 21, 2019 regarding 503B Compounding Pharmacies and the cGMP draft guidance, as well as office stock issues which had generated many comments.
West Pharma

Melanie Prudom

Director, Market Insights, Pharma

Previous Posts
Particle Analysis

June 11, 2019

Particulate Challenges

Fran DeGrazio

Fran DeGrazio

V.P. Technical Customer Service & Scientific Affairs

A nurse extracting a medication from a vial into a syringe

June 04, 2019

Are You Ready? Compliance with New USP Chapters <381>, <382>, <1381> and <1382>

Daniel Bantz

Daniel Bantz

Technical Manager, Packaging & Performance, Laboratory

Introducing Integrated Solutions

May 02, 2019

FDA Guidance Affecting cGMP Compounding Pharmacies (503Bs)

Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

SmartDose Platform

April 26, 2019

Overcoming Challenges Associated with Biologic Drug Formulation and Development

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

What's New In the West Knowledge Center

April 16, 2019

What’s New in the Knowledge Center?

Tara Haarlander

Tara Haarlander

Sr. Specialist, Scientific Communications

Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

April 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

SmartDose Injection Platform in Use

October 16, 2018

Medical Device User Fee Rates

Ana Ladino

Ana Ladino

Director, Regulatory Affairs

Introducing Integrated Solutions

October 08, 2018

Introducing Integrated Solutions

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

Load more